- Filed
- May 4, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 29, 2026 | 62.27M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 61.7M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 61.39M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 59.65M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 59.4M sh |
| Capex | Q2 2026 · Mar 31, 2026 | $17.86M |
| Capex | Q2 2026 · Mar 31, 2025 | $6.41M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$42.37M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$34.41M |
| Short Term Investments | Q2 2026 · Mar 31, 2026 | $49M |
| Short Term Investments | Q2 2026 · Sep 30, 2025 | $49.39M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $122.67M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $183.05M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $455.09M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $456.1M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $472.96M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $440.11M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $455.94M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $472.69M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $119.98M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $91.41M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $221.12M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $168.9M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $323.44M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $332.97M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $676.21M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $641.86M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.71 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$1.21 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$0.66 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$1.19 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.71 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$1.21 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.66 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$1.19 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $76.09M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $145.83M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $63.67M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $119.85M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $19.7M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $36.83M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $23.92M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $45.22M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$44.02M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$74.53M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$39.33M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$70.92M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$45.86M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$78.76M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$41.56M |
| Operating Income | Q2 2026 · Mar 31, 2025 | −$76.21M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $53.59M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $103.32M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $46.77M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $92.64M |
| Revenue | Q2 2026 · Mar 31, 2026 | $110.72M |
| Revenue | Q2 2026 · Mar 31, 2026 | $214.41M |
| Revenue | Q2 2026 · Mar 31, 2025 | $92.79M |
| Revenue | Q2 2026 · Mar 31, 2025 | $181.51M |